Impact of prior SARS-CoV-2 infection and mRNA vaccination on contagiousness and infection risk

PF-07275315 is a monoclonal antibody commercialized by Pfizer, with a leading Phase II program in Atopic Dermatitis (Atopic Eczema).

To ad­dress the con­tin­ued short­age of Pfiz­er’s syphilis drug amid ris­ing cas­es in the US, the FDA has ap­proved the tem­po­rary im­port of ex­ten­cilline from

Although the Centers for Medicare & Medicaid Services (CMS) issued a final rule on prior authorization, there is more that can be done to ease